部分中等收入东南亚国家免疫进展与规划结构的景观分析
本研究基于文献及世界卫生组织、联合国儿童基金会、全球疫苗免疫联盟数据库,以2010年为基线,分析马来西亚、泰国、菲律宾、越南、缅甸五个中等收入东南亚国家的国家免疫规划绩效与结构。马来西亚和泰国维持≥90%覆盖率,菲律宾自2010年以来未达≥90%,2020年最高仅72%。各国均增加政府投入,但筹资模式与疫苗引入受捐赠支持影响。
要点
- 马来西亚和泰国2010至2020年及2021年新冠疫情期间维持≥90%覆盖率。
- 菲律宾自2010年以来未达≥90%覆盖率,2020年最高仅72%。
- 菲律宾2010至2019年每年报告疫苗缺货,共28次缺货事件。
核心结论
- 捐赠支持、创新筹资和国内疫苗生产均对免疫服务高效交付发挥重要作用。
研究设计与样本
- 本研究为景观分析,数据来自已发表文献及世界卫生组织、联合国儿童基金会、全球疫苗免疫联盟数据库,以2010年为基线年。
- 研究覆盖马来西亚、泰国、菲律宾、越南、缅甸五个中等收入东南亚国家。
主要发现
- 马来西亚和泰国2010至2020年及2021年新冠疫情期间维持≥90%覆盖率。
- 越南和受捐赠支持的缅甸2020年大多数常规疫苗覆盖率达80-90%。
- 菲律宾自2010年以来未达≥90%覆盖率,2020年最高仅72%(MCV1和脊灰疫苗3剂)。
- 自2010年以来各国政府免疫筹资至少增加91%(马来西亚)至1897%(缅甸)。
- 缅甸2021年政府筹资仅占免疫成本的32%,仍主要依赖捐赠支持。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study examined the performance and structures of national immunization program in five middle-income Southeast Asian countries - Malaysia, Thailand, Philippines, Viet Nam, and Myanmar, and analyzed how the different structures relate to the difference in program performance to identify effective strategies in the study countries that facilitated good immunization performance. Data were derived from published literature, and WHO/UNICEF/Gavi databases, with 2010 as the baseline year. UMICs Malaysia and Thailand maintained ≥90 % coverage from 2010 to 2020 and even during the COVID-19 pandemic in 2021. LMICs Viet Nam and donor-supported Myanmar also achieved 80-90 % coverage for most routine vaccines in 2020. The Philippines have not reached ≥90 % coverage since 2010, with the maximum only 72 % (MCV1 and Polio3) in 2020. All study countries prioritize immunization and increased government financing since 2010 by minimum 91 % in Malaysia and 1897 % in Myanmar. However, Myanmar still largely depended on donor support with government financing only 32 % of immunization costs in 2021. The Philippines funds 100 % of immunization costs and ensures sustainable financing for the NIP through earmarked "sin tax" revenues from alcohol and tobacco. Donor support influenced new vaccine introductions among the study countries, with Gavi countries Myanmar and Viet Nam introducing more new vaccines, compared to Gavi-ineligible Malaysia and Thailand. The Philippines reported vaccine stock-outs every year amounting to 28 stock-outs events from 2010 to 2019, compared to only 1-4 stockouts in the other study countries. Donor support, innovative financing, and domestic vaccine manufacturing all play an important role in the efficient delivery of immunization services as demonstrated by the several new vaccine introductions and high immunization rates in Myanmar though Gavi and UNICEF support, additional annual $1.2 billion budget for health and immunization from "sin taxes" in the Philippines, and lack of stockouts for vaccines sourced at affordable prices from domestic manufacturers in Viet Nam.
引用
- Basa JE, Clemens R, Clemens SAC, et al. Landscaping analysis of immunization progress and program structures in selected middle income Southeast Asian countries. Vaccine. 2024. PMID: 38448324. doi:10.1016/j.vaccine.2024.02.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。